Literature DB >> 15070986

Evaluation of automated sample preparation and quantitative PCR LCx assay for determination of human immunodeficiency virus type 1 RNA.

Zsofia Muller1, Evelyn Stelzl, Michael Bozic, Josef Haas, Egon Marth, Harald H Kessler.   

Abstract

Efforts have been made to achieve full automation of molecular assays for quantitative detection of human immunodeficiency virus type 1 (HIV-1). In the present study, the Abbott LCx HIV RNA Quantitative assay was evaluated in conjunction with automated HIV-1 RNA extraction on the MagNA Pure LC instrument and compared to the conventional LCx HIV RNA Quantitative assay, which uses a manual nucleic acid extraction protocol. Accuracy, linearity, and interassay and intra-assay variations were determined. The performance of the assay in a routine clinical laboratory was tested with a total of 105 clinical specimens. When the accuracy of the LCx HIV RNA Quantitative assay with the automated sample preparation protocol was tested, all results were found to be within +/- 0.5 log unit of the expected results. Determination of linearity resulted in a quasilinear curve over 3.5 log units. For determination of interassay variation, coefficients of variation were found to be between 21 and 66% for the LCx HIV RNA Quantitative assay with the automated sample preparation protocol and between 10 and 69% for the LCx HIV RNA Quantitative assay with manual sample preparation. For determination of intra-assay variation, coefficients of variation were found to be between 7 and 25% for the LCx HIV RNA Quantitative assay with the automated sample preparation protocol and between 7 and 19% for the LCx HIV RNA Quantitative assay with manual sample preparation. When clinical samples were tested by the LCx HIV RNA Quantitative assay with the automated sample preparation protocol and the results were compared with those of the LCx HIV RNA Quantitative assay with manual sample preparation, 95% of all positive results were found to be within +/- 0.5 log unit. In conclusion, the assay with automated sample preparation proved to be suitable for use in the routine diagnostic laboratory and required significantly less hands-on time.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070986      PMCID: PMC387536          DOI: 10.1128/JCM.42.4.1439-1443.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma.

Authors:  J Johanson; K Abravaya; W Caminiti; D Erickson; R Flanders; G Leckie; E Marshall; C Mullen; Y Ohhashi; R Perry; J Ricci; J Salituro; A Smith; N Tang; M Vi; J Robinson
Journal:  J Virol Methods       Date:  2001-06       Impact factor: 2.014

2.  Fully automated nucleic acid extraction: MagNA Pure LC.

Authors:  H H Kessler; G Mühlbauer; E Stelzl; E Daghofer; B I Santner; E Marth
Journal:  Clin Chem       Date:  2001-06       Impact factor: 8.327

3.  Detection of herpes simplex virus DNA in genital and dermal specimens by LightCycler PCR after extraction using the IsoQuick, MagNA Pure, and BioRobot 9604 methods.

Authors:  M J Espy; P N Rys; A D Wold; J R Uhl; L M Sloan; G D Jenkins; D M Ilstrup; F R Cockerill; R Patel; J E Rosenblatt; T F Smith
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

4.  Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2.

Authors:  K Abravaya; C Esping; R Hoenle; J Gorzowski; R Perry; P Kroeger; J Robinson; R Flanders
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.

Authors:  P Swanson; V Soriano; S G Devare; J Hackett
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

6.  Determination of human immunodeficiency virus type 1 subtypes by a rapid method useful for the routine diagnostic laboratory.

Authors:  H H Kessler; D Deuretzbacher; E Stelzl; E Daghofer; B I Santner; E Marth
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

7.  Evaluation of the abbott LCx HIV-1 RNA quantitative, a new assay for quantitative determination of human immunodeficiency virus type 1 RNA.

Authors:  N Zanchetta; G Nardi; L Tocalli; L Drago; C Bossi; F R Pulvirenti; C Galli; M R Gismondo
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

8.  Predictors of optimal virological response to potent antiretroviral therapy.

Authors:  W G Powderly; M S Saag; S Chapman; G Yu; B Quart; N J Clendeninn
Journal:  AIDS       Date:  1999-10-01       Impact factor: 4.177

9.  Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O.

Authors:  M P de Baar; M W van Dooren; E de Rooij; M Bakker; B van Gemen; J Goudsmit; A de Ronde
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

Review 10.  Automation of laboratory testing for infectious diseases using the polymerase chain reaction-- our past, our present, our future.

Authors:  D Jungkind
Journal:  J Clin Virol       Date:  2001-01       Impact factor: 3.168

View more
  8 in total

Review 1.  Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

Authors:  Ming Guan
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

Review 2.  International standards and reference materials for quantitative molecular infectious disease testing.

Authors:  Roberta M Madej; Jack Davis; Marcia J Holden; Stan Kwang; Emmanuel Labourier; George J Schneider
Journal:  J Mol Diagn       Date:  2010-01-14       Impact factor: 5.568

3.  Comparison of the LCx human immunodeficiency virus (HIV) RNA quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan assays for quantitation of HIV type 1 RNA in plasma.

Authors:  Vincent Foulongne; Brigitte Montes; Marie-Noelle Didelot-Rousseau; Michel Segondy
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

4.  The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience.

Authors:  John V Williams; Chiaoyin K Wang; Chin-Fen Yang; Sharon J Tollefson; Frances S House; Josh M Heck; Marla Chu; Jennifer B Brown; Linda D Lintao; Joe D Quinto; David Chu; Richard R Spaete; Kathryn M Edwards; Peter F Wright; James E Crowe
Journal:  J Infect Dis       Date:  2005-12-30       Impact factor: 5.226

5.  Generation of HIV-1 and Internal Control Transcripts as Standards for an In-House Quantitative Competitive RT-PCR Assay to Determine HIV-1 Viral Load.

Authors:  Anny Armas Cayarga; Yenitse Perea Hernández; Yaimé J González González; Santiago Dueñas Carrera; Idania González Pérez; René Robaina Álvarez
Journal:  Biotechnol Res Int       Date:  2011-06-23

6.  Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain.

Authors:  Christian Drosten; Marcus Panning; Jan Felix Drexler; Florian Hänsel; Celia Pedroso; Jane Yeats; Luciano Kleber de Souza Luna; Matthew Samuel; Britta Liedigk; Ute Lippert; Martin Stürmer; Hans Wilhelm Doerr; Carlos Brites; Wolfgang Preiser
Journal:  Clin Chem       Date:  2006-04-20       Impact factor: 8.327

7.  Automated Trimethyl Sulfonium Hydroxide Derivatization Method for High-Throughput Fatty Acid Profiling by Gas Chromatography-Mass Spectrometry.

Authors:  Paul Gries; Atul Singh Rathore; Xiyuan Lu; Jennifer Chiou; Yen Bao Huynh; Alessia Lodi; Stefano Tiziani
Journal:  Molecules       Date:  2021-10-15       Impact factor: 4.927

8.  Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review.

Authors:  Eline L Korenromp; Brian G Williams; George P Schmid; Christopher Dye
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.